Gregory J Wilson

1PUBLICATIONS
8CO-AUTHORS
Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Dec 13, 2024
HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines.

Gregory J Wilson, L W Preston Church, Colleen F Kelley

Pageof 1

Frequent Collaborators

1 joint publications

Colleen F Kelley

1 joint publications

Samuel T Robinson

1 joint publications

Briana D Furch

1 joint publications

Youyi Fong

1 joint publications

Carmen A Paez

1 joint publications

Margaret Yacovone

1 joint publications

David C Montefiori

1 joint publications

Lawrence Corey

Frequent Collaborators

1 joint publications

Colleen F Kelley

1 joint publications

Samuel T Robinson

1 joint publications

Briana D Furch

1 joint publications

Youyi Fong

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on : Jun 23, 2011

19.5K
See more related videos

Top Related Videos

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on : Jun 23, 2011

19.5K
See more related videos